Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04179461 · ClinicalTrials.gov registry record · Phase 2
Personalized Treatment Algorithms for Difficult-to-treat Asthma
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 21
- Enrollment target
NCT04179461 is a Phase 2 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 21 participants.
The verdict
NCT04179461, a Phase 2 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 21 participants
- Enrollment target
Study Summary
Asthma is a common, complex and costly chronic condition. Moreover, asthma is heterogeneous in terms of treatment response. This heterogeneity contributes to the difficulty in both studying and treating asthma. This is a pilot study to improve health outcomes in youths with difficult to treat asthma with ongoing symptoms and healthcare utilization despite medium to high doses of inhaled corticosteroids. Asthma heterogeneity in both disease pathophysiology and treatment response contributes to the difficulty in both studying and managing asthma. In order to begin to develop personalized algorithms for patients, investigators need to model novel biomarkers and other factors that contribute to individual differences in asthma outcome and test other factors that contribute to individual differences in asthma outcome and test personalized treatment strategies.
Interventions
- DRUG Azithromycin
- DRUG Cholecalciferol
- DRUG antihistamine
- DRUG Fluticasone Propionate
- DRUG emollient cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2019-10-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04179461
The ClinicalTrials.gov registry entry for NCT04179461 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Azithromycin is the first listed.
NCT04179461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04179461 about?
NCT04179461 is a clinical study titled "Personalized Treatment Algorithms for Difficult-to-treat Asthma". Asthma is a common, complex and costly chronic condition. Moreover, asthma is heterogeneous in terms of treatment response. This heterogeneity contributes to the difficulty in both studying and treating asthma. This is a pilot study to improve health outcomes in youths with difficult to treat asthma...
What is the current status of trial NCT04179461?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 21 participants. The study started on 2018-03-16. Estimated completion is 2019-10-03.
What interventions are being tested in trial NCT04179461?
The interventions under investigation include: Azithromycin (DRUG), Cholecalciferol (DRUG), antihistamine (DRUG), Fluticasone Propionate (DRUG), emollient cream (DRUG).
Who is sponsoring clinical trial NCT04179461?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.